• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CPEB3 介导的 MTDH mRNA 翻译抑制抑制肝癌进展。

CPEB3-mediated MTDH mRNA translational suppression restrains hepatocellular carcinoma progression.

机构信息

Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang, 150081, China.

Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150081, China.

出版信息

Cell Death Dis. 2020 Sep 23;11(9):792. doi: 10.1038/s41419-020-02984-y.

DOI:10.1038/s41419-020-02984-y
PMID:32968053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7511356/
Abstract

Cytoplasmic polyadenylation element-binding protein 3 (CPEB3) is a sequence-specific RNA-binding protein. We had reported that CPEB3 is involved in hepatocellular carcinoma (HCC) progression. However, the underlying mechanisms of CPEB3 in HCC remain unclear. In this study, we firstly performed RNA immunoprecipitation to uncover the transcriptome-wide CPEB3-bound mRNAs (CPEB3 binder) in HCC. Bioinformatic analysis indicates that CPEB3 binders are closely related to cancer progression, especially HCC metastasis. Further studies confirmed that metadherin (MTDH) is a direct target of CPEB3. CPEB3 can suppress the translation of MTDH mRNA in vivo and in vitro. Besides, luciferase assay demonstrated that CPEB3 interacted with 3'-untranslated region of MTDH mRNA and inhibited its translation. Subsequently, CPEB3 inhibited the epithelial-mesenchymal transition and metastasis of HCC cells through post-transcriptional regulation of MTDH. In addition, cpeb3 knockout mice are more susceptible to carcinogen-induced hepatocarcinogenesis and subsequent lung metastasis. Our results also indicated that CPEB3 was a good prognosis marker, which is downregulated in HCC tissue. In conclusion, our results demonstrated that CPEB3 played an important role in HCC progression and targeting CPEB3-mediated mRNA translation might be a favorable therapeutic approach.

摘要

细胞质多聚腺苷酸化元件结合蛋白 3(CPEB3)是一种序列特异性 RNA 结合蛋白。我们曾报道 CPEB3 参与肝细胞癌(HCC)的进展。然而,CPEB3 在 HCC 中的潜在机制仍不清楚。在这项研究中,我们首先进行 RNA 免疫沉淀,以揭示 HCC 中 CPEB3 结合的转录组范围的 mRNAs(CPEB3 结合物)。生物信息学分析表明,CPEB3 结合物与癌症进展密切相关,特别是 HCC 转移。进一步的研究证实,metadherin(MTDH)是 CPEB3 的直接靶标。CPEB3 可以在体内和体外抑制 MTDH mRNA 的翻译。此外,荧光素酶测定表明 CPEB3 与 MTDH mRNA 的 3'-非翻译区相互作用并抑制其翻译。随后,CPEB3 通过对 MTDH 的转录后调节抑制 HCC 细胞的上皮-间充质转化和转移。此外,cpeb3 敲除小鼠对致癌物诱导的肝癌发生和随后的肺转移更敏感。我们的结果还表明 CPEB3 是一种预后良好的标志物,在 HCC 组织中下调。总之,我们的结果表明 CPEB3 在 HCC 进展中发挥重要作用,靶向 CPEB3 介导的 mRNA 翻译可能是一种有利的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/181c9fb7b1df/41419_2020_2984_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/f9daaea08fb2/41419_2020_2984_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/0d100d24a769/41419_2020_2984_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/61ae0629b1e8/41419_2020_2984_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/31f63dc7b9f2/41419_2020_2984_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/0a96b318f8a0/41419_2020_2984_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/a856be11a761/41419_2020_2984_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/27dd0fec3f42/41419_2020_2984_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/181c9fb7b1df/41419_2020_2984_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/f9daaea08fb2/41419_2020_2984_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/0d100d24a769/41419_2020_2984_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/61ae0629b1e8/41419_2020_2984_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/31f63dc7b9f2/41419_2020_2984_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/0a96b318f8a0/41419_2020_2984_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/a856be11a761/41419_2020_2984_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/27dd0fec3f42/41419_2020_2984_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/7511356/181c9fb7b1df/41419_2020_2984_Fig8_HTML.jpg

相似文献

1
CPEB3-mediated MTDH mRNA translational suppression restrains hepatocellular carcinoma progression.CPEB3 介导的 MTDH mRNA 翻译抑制抑制肝癌进展。
Cell Death Dis. 2020 Sep 23;11(9):792. doi: 10.1038/s41419-020-02984-y.
2
MiR-9-5p promotes cell proliferation and migration of hepatocellular carcinoma by targeting CPEB3.miR-9-5p 通过靶向 CPEB3 促进肝癌细胞的增殖和迁移。
Biomark Med. 2021 Feb;15(2):97-108. doi: 10.2217/bmm-2020-0322. Epub 2021 Jan 26.
3
Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.Metadherin 通过诱导上皮-间充质转化促进肝癌转移。
Clin Cancer Res. 2011 Dec 1;17(23):7294-302. doi: 10.1158/1078-0432.CCR-11-1327. Epub 2011 Oct 5.
4
MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3.微小RNA-20b-5p通过下调CPEB3促进肝癌细胞增殖、迁移和侵袭。
Ann Hepatol. 2021 Jul-Aug;23:100345. doi: 10.1016/j.aohep.2021.100345. Epub 2021 Mar 31.
5
MiR-224 Executes a Tumor Accelerative Role during Hepatocellular Carcinoma Malignancy by Targeting Cytoplasmic Polyadenylation Element-Binding Protein 3.miR-224 通过靶向细胞质多聚腺苷酸化元件结合蛋白 3 在肝细胞癌恶性进展中发挥肿瘤促进作用。
Pharmacology. 2020;105(7-8):477-487. doi: 10.1159/000506711. Epub 2020 May 26.
6
Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-β-catenin signaling pathway.METADHERIN-PRMT5 复合物通过 WNT-β-连环蛋白信号通路增强肝癌的转移。
Carcinogenesis. 2020 Apr 22;41(2):130-138. doi: 10.1093/carcin/bgz065.
7
Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.微小RNA-30a-5p的过表达通过靶向MTDH/PTEN/AKT通路抑制肝癌细胞增殖并诱导其凋亡。
Tumour Biol. 2016 May;37(5):5885-95. doi: 10.1007/s13277-015-4456-1. Epub 2015 Nov 21.
8
MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3.miR-18a-5p 通过靶向 CPEB3 促进肝细胞癌的进展。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211043976. doi: 10.1177/15330338211043976.
9
Zingerone suppresses proliferation, invasion, and migration of hepatocellular carcinoma cells by the inhibition of MTDH-mediated PI3K/Akt pathway.荜澄茄酮通过抑制 MTDH 介导的 PI3K/Akt 通路抑制肝癌细胞的增殖、侵袭和迁移。
J Recept Signal Transduct Res. 2022 Aug;42(4):409-417. doi: 10.1080/10799893.2021.1988970. Epub 2021 Oct 13.
10
MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma.微小RNA-107:一种靶向人肝细胞癌中CPEB3/EGFR轴的肿瘤进展新促进因子。
Oncotarget. 2016 Jan 5;7(1):266-78. doi: 10.18632/oncotarget.5689.

引用本文的文献

1
MAGI2-AS3/miR-450b-5p/COLEC10 interaction network: A potential therapeutic and prognostic marker in hepatocellular carcinoma.MAGI2-AS3/miR-450b-5p/COLEC10相互作用网络:肝细胞癌潜在的治疗和预后标志物
ILIVER. 2025 Feb 13;4(1):100146. doi: 10.1016/j.iliver.2025.100146. eCollection 2025 Mar.
2
Construction of a Prognostic Model Using RNA Processing Factor Genes and the Key Role of NSUN6 in Glioma Outcomes.利用RNA加工因子基因构建预后模型及NSUN6在胶质瘤预后中的关键作用
J Cell Mol Med. 2025 Jun;29(12):e70668. doi: 10.1111/jcmm.70668.
3
Astrocyte Elevated Gene-1/Metadherin (AEG-1/MTDH): A Promising Molecular Marker and Therapeutic Target for Hepatocellular Carcinoma.

本文引用的文献

1
CPEB3 inhibits translation of mRNA targets by localizing them to P bodies.CPEB3 通过将其 mRNA 靶标定位到 P 体中来抑制翻译。
Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):18078-18087. doi: 10.1073/pnas.1815275116. Epub 2019 Aug 15.
2
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.WebGestalt 2019:基因集分析工具包,具有全新的用户界面和 API。
Nucleic Acids Res. 2019 Jul 2;47(W1):W199-W205. doi: 10.1093/nar/gkz401.
3
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis.
星形胶质细胞上调基因1/黏附素(AEG-1/MTDH):一种有前景的肝细胞癌分子标志物和治疗靶点。
Cancers (Basel). 2025 Apr 21;17(8):1375. doi: 10.3390/cancers17081375.
4
MiR-103-3p regulates chondrocyte autophagy, apoptosis, and ECM degradation through the PI3K/Akt/mTOR pathway by targeting CPEB3.微小RNA-103-3p通过靶向CPEB3,经由PI3K/Akt/mTOR信号通路调控软骨细胞的自噬、凋亡及细胞外基质降解。
J Orthop Surg Res. 2025 Mar 29;20(1):324. doi: 10.1186/s13018-025-05719-x.
5
A Novel RNA Methylation-Related Prognostic Signature and its Tumor Microenvironment Characterization in Hepatocellular Carcinoma.新型 RNA 甲基化相关预后标志物及其在肝细胞癌中的肿瘤微环境特征。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241276895. doi: 10.1177/15330338241276895.
6
Prognostic insights, immune infiltration, and therapeutic response: Cytoplasmic poly(A) tail regulators in hepatocellular carcinoma.预后见解、免疫浸润与治疗反应:肝细胞癌中的细胞质聚腺苷酸尾调控因子
Mol Ther Oncol. 2024 May 22;32(2):200816. doi: 10.1016/j.omton.2024.200816. eCollection 2024 Jun 20.
7
Screening of miRNAs as prognostic biomarkers and their associated hub targets across Hepatocellular carcinoma using survival-based bioinformatics approach.基于生存的生物信息学方法筛选肝细胞癌中作为预后生物标志物的miRNA及其相关枢纽靶点。
J Genet Eng Biotechnol. 2024 Mar;22(1):100337. doi: 10.1016/j.jgeb.2023.100337. Epub 2024 Jan 24.
8
Tumor-associated macrophages and PD-L1 in prostate cancer: a possible key to unlocking immunotherapy efficacy.肿瘤相关巨噬细胞和 PD-L1 在前列腺癌中的作用:解锁免疫治疗疗效的关键。
Aging (Albany NY). 2024 Jan 4;16(1):445-465. doi: 10.18632/aging.205378.
9
Comprehensively analysis of splicing factors to construct prognosis prediction classifier in prostate cancer.全面分析剪接因子构建前列腺癌预后预测分类器。
J Cell Mol Med. 2023 Sep;27(18):2684-2700. doi: 10.1111/jcmm.17849. Epub 2023 Aug 9.
10
Integrated analysis of RNA-seq in hepatocellular carcinoma reveals competing endogenous RNA network composed of circRNA, lncRNA, and mRNA.肝细胞癌中 RNA-seq 的综合分析揭示了由 circRNA、lncRNA 和 mRNA 组成的竞争内源性 RNA 网络。
Medicine (Baltimore). 2023 Feb 22;102(8):e32915. doi: 10.1097/MD.0000000000032915.
GEPIA2:一个用于大规模表达谱分析和交互式分析的增强型网络服务器。
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560. doi: 10.1093/nar/gkz430.
4
Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.Mir-452-3p:一种靶向人类肝细胞癌中CPEB3/EGFR轴的潜在肿瘤促进因子。
Technol Cancer Res Treat. 2017 Dec;16(6):1136-1149. doi: 10.1177/1533034617735931. Epub 2017 Nov 5.
5
RNA-Binding Proteins in Cancer: Old Players and New Actors.癌症中的RNA结合蛋白:老面孔与新角色
Trends Cancer. 2017 Jul;3(7):506-528. doi: 10.1016/j.trecan.2017.05.003. Epub 2017 Jun 20.
6
The essential role of MTDH in the progression of HCC: a study with immunohistochemistry, TCGA, meta-analysis and investigation.MTDH在肝癌进展中的关键作用:一项免疫组织化学、癌症基因组图谱(TCGA)、荟萃分析及调查研究
Am J Transl Res. 2017 Apr 15;9(4):1561-1579. eCollection 2017.
7
Circadian- and UPR-dependent control of CPEB4 mediates a translational response to counteract hepatic steatosis under ER stress.生物钟和 UPRE 依赖性控制的 CPEB4 介导了一种翻译反应,以抵消内质网应激下的肝脂肪变性。
Nat Cell Biol. 2017 Feb;19(2):94-105. doi: 10.1038/ncb3461. Epub 2017 Jan 16.
8
Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers.CPEB4 在调控黑色素瘤驱动基因中的细胞内多聚腺苷酸化因子的谱系特异性作用。
Nat Commun. 2016 Nov 18;7:13418. doi: 10.1038/ncomms13418.
9
Loss of CPEB3 Upregulates MEGF10 to Impair Mosaic Development of ON Starburst Amacrine Cells.CPEB3缺失上调MEGF10以损害视盘星爆无长突细胞的镶嵌发育。
Front Mol Neurosci. 2016 Oct 24;9:105. doi: 10.3389/fnmol.2016.00105. eCollection 2016.
10
Enhancement of DEN-induced liver tumorigenesis in heme oxygenase-1 G143H mutant transgenic mice.血红素加氧酶-1 G143H突变转基因小鼠中DEN诱导的肝脏肿瘤发生增强。
Biochem Biophys Res Commun. 2016 Dec 2;481(1-2):169-175. doi: 10.1016/j.bbrc.2016.10.148. Epub 2016 Oct 31.